 Preleukemia
"Preleukemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.
| Descriptor ID |
D011289
|
| MeSH Number(s) |
C04.834.770 C15.378.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Preleukemia".
Below are MeSH descriptors whose meaning is more specific than "Preleukemia".
This graph shows the total number of publications written about "Preleukemia" by people in this website by year, and whether "Preleukemia" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1985 | 1 | 1 | 2 | | 1986 | 1 | 0 | 1 | | 1990 | 1 | 0 | 1 | | 1996 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2014 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Preleukemia" by people in Profiles.
-
Vasanthakumar A, Godley LA. On the origin of leukemic species. Cell Stem Cell. 2014 Apr 03; 14(4):421-2.
-
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellström-Lindberg E, Tefferi A, Bloomfield CD. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30; 114(5):937-51.
-
Nand S, Stock W, Godwin J, Fisher SG. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Am J Hematol. 1996 May; 52(1):42-6.
-
Dayton MA, van Besien K, Tricot G, Hoffman R. Preleukemic state preceding adult acute lymphoblastic leukemia. Am J Med. 1990 Nov; 89(5):657-62.
-
Pierre RV, Catovsky D, Mufti GJ, Swansbury GJ, Mecucci C, Dewald GW, Ruutu T, Van Den Berghe H, Rowley JD, Mitelman F, et al. Clinical-cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genet Cytogenet. 1989 Jul 15; 40(2):149-61.
-
Preisler HD, Raza A, Barcos M, Azarnia N, Larson R, Browman G, Walker I, Grunwald H, D'Arrigo P, Stein A, et al. High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study. Am J Hematol. 1986 Oct; 23(2):131-4.
-
Winter JN, Variakojis D, Gaynor ER, Larson RA, Miller KB. Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia. Cancer. 1985 Aug 01; 56(3):443-9.
-
Larson RA. Management of myelodysplastic syndromes. Ann Intern Med. 1985 Jul; 103(1):136-8.
-
Rowley JD. General report on the Second International Workshop on Chromosomes in Leukemia. Int J Cancer. 1980 Nov 15; 26(5):531-3.
-
Roth DG, Richman CM, Rowley JD. Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosome. Blood. 1980 Aug; 56(2):262-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|